Cataplasm-based controlled drug delivery: Development and optimization of a novel formulation

被引:21
作者
Agarwal, V [1 ]
Singh, SK [1 ]
Reddy, IK [1 ]
Durrani, MJ [1 ]
Khan, MA [1 ]
机构
[1] Texas Tech Univ, Ctr Hlth Sci, Dept Pharmaceut Sci, Sch Pharm, Amarillo, TX 79106 USA
关键词
D O I
10.1081/DDC-100102222
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
The objective of the present study was to study the formulation variables involved in the development of a novel plasterlike preparation (cataplasm) and to optimize important formulation variables with an aim to maximize the in vitro release of the drug with minimum lag time. Cataplasm was prepared by dispersing a model drug (ibuprofen), humectant (glycerol), adhesive (Indopol H100(R)), polymer (Carbopol C934P(R)) with other formulation ingredients in a beaker with an open-blade impeller. The paste was cast on a nonocclusive backing membrane and dried overnight. The diffusion of the model drug was studied across a cellulosic membrane using Franz's diffusion cells. The amounts of three formulation variables, carbopol (X-1), glycerol (X-2), and indopol (X-3) were studied at three levels, and a face-centered cubic design was used to maximize the flux. An optimization procedure for maximum flux and minimum lag time predicted a flux of 97.22 mcg/cm(2)/hr at X-1 (2% w/w), X-2 (11.75% w/w), and X-3 (6% w/w). An experimental patch prepared with the above concentrations yielded a flux of 90.7 mcg/cm(2)/hr.
引用
收藏
页码:659 / 665
页数:7
相关论文
共 9 条
[1]
SOME FACTORS AFFECTING THE INVITRO PENETRATION OF IBUPROFEN THROUGH HUMAN SKIN [J].
BIALIK, W ;
WALTERS, KA ;
BRAIN, KR ;
HADGRAFT, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 92 (1-3) :219-223
[2]
DREISER RL, 1993, DRUG EXP CLIN RES, V19, P117
[3]
GALEAZZI M, 1993, DRUG EXP CLIN RES, V19, P107
[4]
JENOURE P, 1993, DRUG EXP CLIN RES, V19, P125
[5]
HYDROGELS - SWELLING, DRUG LOADING, AND RELEASE [J].
KIM, SW ;
BAE, YH ;
OKANO, T .
PHARMACEUTICAL RESEARCH, 1992, 9 (03) :283-290
[6]
ROSENTHAL M, 1993, DRUG EXP CLIN RES, V19, P99
[7]
SASAKI H, 1987, CHEM PHARM BULL, V35, P4883
[8]
Atenolol gastrointestinal therapeutic system: Optimization of formulation variables using response surface methodology [J].
Sastry, SV ;
Reddy, IK ;
Khan, MA .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (02) :121-130
[9]
1993, XSTAT VERSION 2 0